Which Hedge Funds Own SPRY — Ars Pharmaceuticals, Inc. Comm

15 of the hedge funds we track hold SPRY, worth $248.5M combined as of the Q2 2026 13F filings (preliminary, still landing).

Versus the prior quarter: 4 opened a new position, 3 added, 4 trimmed, 3 exited.

10 of those are hedged quant multi-strategy books, not directional conviction.

Insider buying at SPRY · All tracked funds